Taken together, we assume that adiponectin may alleviate the BBB disruption in AD (1) by inhibiting apoptosis of brain endothelial cells, (2) by protecting tight junction integrity, and (3) by mediating the balance of Aβ transporters in brain endothelial cells. Here, ADIPOQ is linked to Alzheimer disease.